Expand Content

Xiuli Liu, MD, PhD


Xiuli Liu, MD, PhD

Appointed: 2007

Xiuli Liu, MD, PhD
Department: Anatomic Pathology
Location: Cleveland Clinic Main Campus
Mail Code L25
9500 Euclid Avenue
Cleveland, OH 44195
Type of Doctor:
Adults Only

Biographical Sketch

Xiuli Liu, MD, PhD, is  board-certified in both anatomic and clinical pathology. She joined the Department of Anatomic Pathology of Cleveland Clinic as Associate Staff in 2007 with special diagnostic interests in gastrointestinal tract, liver and pancreas pathology. Her research interests include fatty liver disease, ischemic injury in the gastrointestinal tract and carcinogenesis of colorectal and pancreatic carcinoma.

Education & Fellowships

Fellowship - University of Alabama Hospital
G. I. Pathology
Birmingham, AL USA
Residency - University of Alabama Hospital
Birmingham, AL USA
Doctorate - University of Arkansas for Medical Sciences
Little Rock, AR USA
Graduate - University of Arkansas for Medical Sciences
Little Rock, AR USA
Medical School - Beijing Medical University Faculty of Medicine
Beijing China


  • Anatomic & Clinical Pathology

Specialty Interests

gastrointestinal pathology, Hepatic Pathology


  • United States and Canadian Academy of Pathology, Since 2006
  • College of American Pathologists, Since 2006
  • American Society of Clinical Pathology, Since 2007

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 5/29/2014, Dr. Liu has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • Chinese
  • English